A detailed history of Roberts Glore & CO Inc transactions in Bio Techne Corp stock. As of the latest transaction made, Roberts Glore & CO Inc holds 25,920 shares of TECH stock, worth $1.9 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares
25,920
Previous 26,080 0.61%
Holding current value
$1.9 Million
Previous $1.87 Million 10.87%
% of portfolio
0.61%
Previous 0.57%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$70.96 - $82.35 $11,353 - $13,176
-160 Reduced 0.61%
25,920 $2.07 Million
Q1 2024

May 09, 2024

SELL
$65.98 - $77.09 $1,847 - $2,158
-28 Reduced 0.11%
26,080 $1.84 Million
Q3 2023

Nov 13, 2023

SELL
$67.52 - $89.42 $1,215 - $1,609
-18 Reduced 0.07%
26,108 $1.78 Million
Q2 2023

Aug 14, 2023

SELL
$73.76 - $85.98 $28,618 - $33,360
-388 Reduced 1.46%
26,126 $2.13 Million
Q1 2023

May 08, 2023

SELL
$71.62 - $86.62 $7,018 - $8,488
-98 Reduced 0.37%
26,514 $1.97 Million
Q4 2022

Feb 13, 2023

BUY
$80.67 - $352.29 $1.58 Million - $6.89 Million
19,564 Added 277.58%
26,612 $2.21 Million
Q3 2022

Nov 07, 2022

SELL
$282.54 - $391.85 $16,387 - $22,727
-58 Reduced 0.82%
7,048 $2 Million
Q2 2022

Aug 11, 2022

SELL
$322.67 - $449.65 $18,392 - $25,630
-57 Reduced 0.8%
7,106 $2.46 Million
Q1 2022

May 02, 2022

SELL
$353.85 - $487.79 $19,107 - $26,340
-54 Reduced 0.75%
7,163 $3.1 Million
Q4 2021

Feb 11, 2022

SELL
$456.15 - $525.06 $31,474 - $36,229
-69 Reduced 0.95%
7,217 $3.73 Million
Q3 2021

Nov 12, 2021

SELL
$444.87 - $538.88 $266,922 - $323,328
-600 Reduced 7.61%
7,286 $3.53 Million
Q2 2021

Aug 10, 2021

SELL
$387.35 - $450.26 $38,735 - $45,026
-100 Reduced 1.25%
7,886 $3.55 Million
Q1 2021

May 06, 2021

SELL
$314.62 - $411.0 $17,933 - $23,427
-57 Reduced 0.71%
7,986 $3.05 Million
Q4 2020

Feb 09, 2021

SELL
$246.9 - $321.87 $1,234 - $1,609
-5 Reduced 0.06%
8,043 $2.55 Million
Q3 2020

Nov 06, 2020

BUY
$232.22 - $282.96 $1.87 Million - $2.28 Million
8,048 New
8,048 $1.99 Million
Q4 2019

Feb 13, 2020

SELL
$189.68 - $222.09 $1.11 Million - $1.3 Million
-5,851 Closed
0 $0
Q3 2019

Nov 08, 2019

SELL
$183.56 - $216.72 $10,279 - $12,136
-56 Reduced 0.95%
5,851 $1.15 Million
Q2 2019

Aug 09, 2019

SELL
$188.72 - $215.43 $20,759 - $23,697
-110 Reduced 1.83%
5,907 $1.23 Million
Q1 2019

May 14, 2019

SELL
$136.09 - $200.44 $6,804 - $10,022
-50 Reduced 0.82%
6,017 $1.2 Million
Q4 2018

Feb 08, 2019

SELL
$132.75 - $203.8 $16,328 - $25,067
-123 Reduced 1.99%
6,067 $878,000
Q3 2018

Nov 09, 2018

SELL
$147.44 - $204.11 $194,620 - $269,425
-1,320 Reduced 17.58%
6,190 $1.26 Million
Q2 2018

Aug 10, 2018

SELL
$144.9 - $165.58 $26,951 - $30,797
-186 Reduced 2.42%
7,510 $1.11 Million
Q1 2018

May 08, 2018

SELL
$131.46 - $151.04 $46,011 - $52,864
-350 Reduced 4.35%
7,696 $1.16 Million
Q4 2017

Feb 09, 2018

SELL
$121.17 - $134.75 $4,362 - $4,851
-36 Reduced 0.45%
8,046 $1.04 Million
Q3 2017

Nov 08, 2017

SELL
$113.59 - $123.78 $28,397 - $30,945
-250 Reduced 3.0%
8,082 $977,000
Q2 2017

Aug 15, 2017

BUY
N/A
8,332
8,332 $979,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.87B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Roberts Glore & CO Inc Portfolio

Follow Roberts Glore & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Roberts Glore & CO Inc , based on Form 13F filings with the SEC.

News

Stay updated on Roberts Glore & CO Inc with notifications on news.